Novo Holdings Inozyme Pharma, Inc. (INZY) insider trading activity
Novo Holdings is > 10% Shareholder of Inozyme Pharma, Inc.. Currently has a direct ownership of 2.19 Million shares of INZY, which is worth approximately $6.56 Million. The most recent transaction as insider was on Jan 28, 2021, when has been sold 375,000 shares (Common Stock) at a price of $21.0 per share, resulting in proceeds of $7,875,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.19M
0%
3M change
0%
12M change
Total Value Held
$6.56 Million
Novo Holdings Transaction History
Also insider at
NH
Novo Holdings
> 10% Shareholder
Hellerup, G7